Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celularity IncCELU · Entity 7145 | See Remarks | April 13, 2023 | April 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celularity Inc
Report date April 13, 2023 · Filed April 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 351,192 |
Reported balance
After 2023-04-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-04-13 · Tax withholding · Disposed 2,884 · Balance 351,192 F1: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale. F2: Includes 337,108 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.
F2: Includes 337,108 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2023 Filed Apr 18, 2023 01:12 UTC | Celularity Inc CELU · Entity 7145 | Tax withholdingClass A Common Stock | 2,884 | $0.71 | $2,059.46 |
DisclosureSEC source: 0000899243-23-011336 · doc4.xml · nonDerivative · entry 1 Glover Bradley · CIK 0001867698 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,192 F1 · shares: Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale. F2 · balance_after: Includes 337,108 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. Read SEC document |
| February 17, 2023 Filed Feb 23, 2023 02:21 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 300,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-005918 · doc4.xml · nonDerivative · entry 1 Glover Bradley · CIK 0001867698 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,076 F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. F2 · balance_after: These shares include 345,310 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. Read SEC document |
| July 13, 2022 Filed Jul 16, 2022 01:03 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 38,481 | $0.00 Strike: $10.16 | $0.00 |
DisclosureSEC source: 0000899243-22-026196 · doc4.xml · derivative · entry 2 Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,481 Underlying: Class A Common Stock · 38,481 shares Expires 2032-07-13 F2 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| July 13, 2022 Filed Jul 16, 2022 01:03 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 13,124 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-026196 · doc4.xml · nonDerivative · entry 1 Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,810 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| April 13, 2022 Filed Apr 29, 2022 00:55 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 57,721 | $0.00 Strike: $10.16 | $0.00 |
DisclosureSEC source: 0000899243-22-015904 · doc4.xml · derivative · entry 2 Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,721 Underlying: Class A Common Stock · 57,721 shares Expires 2032-04-13 F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| April 13, 2022 Filed Apr 29, 2022 00:55 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 19,686 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-015904 · doc4.xml · nonDerivative · entry 1 Glover Bradley · CIK 0001867698 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,686 F1 · price: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. Read SEC document |
| November 16, 2021 Filed Nov 19, 2022 01:16 UTC | Celularity Inc CELU · Entity 7145 | Tax withholdingClass A Common Stock | 3,734 | $1.89 | $7,057.26 |
DisclosureSEC source: 0000899243-22-036452 · doc4.xml · nonDerivative · entry 2 Glover Bradley · CIK 0001867698 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,076 F3 · shares: Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under 2021 Plan and does not represent a sale. F4 · balance_after: Includes 45,310 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. Read SEC document |
| November 16, 2021 Filed Nov 19, 2022 01:16 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-036452 · doc4.xml · nonDerivative · entry 1 Glover Bradley · CIK 0001867698 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,810 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. F2 · balance_after: Represents 57,810 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 01:21 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Option (Right to Buy) · Derivative | 96,074 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001209191-21-047516 · doc4.xml · derivative · entry 1 Glover Bradley · CIK 0001867698 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,074 Underlying: Class A Common Stock · 96,074 shares Expires 2021-07-16 F2 · price: Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the "Business Combination Agreement"), by and among GX Acquisition Corp. ("GX"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. ("Legacy Celularity"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to "Celularity Inc." F1 · derivative.exercise_date: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 24, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.